Dual time-point 18F-FDG PET/CT to assess response to radiofrequency ablation of lung metastases

被引:5
|
作者
Lafuente, S. [1 ]
Fuster, D. [1 ]
Arguis, P. [2 ]
Granados, U. [1 ]
Perlaza, P. [1 ]
Paredes, P. [1 ]
Vollmer, I. [2 ]
Sanchez, M. [2 ]
Lomena, F. [1 ]
机构
[1] Hosp Clin Barcelona, Dept Nucl Med, Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Radiol, Barcelona, Spain
来源
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR | 2016年 / 35卷 / 04期
关键词
PET/CT; Delayed images; Radiofrequency; Lung metastases; Gastrointestinal cancer; FOLLOW-UP; PERCUTANEOUS RADIOFREQUENCY; PULMONARY NODULES; FDG-PET/CT; CT; TUMORS;
D O I
10.1016/j.remn.2015.12.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim: To establish the usefulness of dual time-point PET/CT imaging in determining the response to radiofrequency ablation (RFA) of solitary lung metastases from gastrointestinal cancer. Materials and methods: This prospective study included 18 cases (3 female, 15 male, mean age 71 +/- 15 yrs) with solitary lung metastases from malignant digestive tract tumors candidates for RFA. PET/CT images 1 h after injection of 4.07 MBq/kg of F-18-FDG (standard images) were performed at baseline, 1 month, and 3 months after RFA. PET/CT images 2 h after injection centered in the thorax at 1 month after RFA were also performed (delayed images). A retention index (RI) of dual time-point images was calculated as follows: RI = (SUVmax delayed image - SUVmax standard image/SUVmax standard image) *100. Pathological confirmation of residual tumor by histology of the treated lesion was considered as local recurrence. A negative imaging follow-up was considered as complete response. Results: Local recurrence was found in 6/18 lesions, and complete response in the remaining 12. The mean percentage change in SUVmax at 1 month and at 3 months showed a sensitivity and specificity for PET/CT of 50% and 33%, and 67% and 92%, respectively. The RI at 1 month after RFA showed a sensitivity and specificity of 83% and 92%, respectively. Conclusions: Dual time point PET/CT can predict the outcome at one month after RFA in lung metastases from digestive tract cancers. The RI can be used to indicate the need for further procedures to rule out persistent tumor due to incomplete RFA. (C) 2015 Elsevier Espana, S.L.U. y SEMNIM. All rights reserved.
引用
收藏
页码:226 / 231
页数:6
相关论文
共 50 条
  • [11] Thoracic Staging in Lung Cancer: Prospective Comparison of 18F-FDG PET/MR Imaging and 18F-FDG PET/CT
    Heusch, Philipp
    Buchbender, Christian
    Koehler, Jens
    Nensa, Felix
    Gauler, Thomas
    Gomez, Benedikt
    Reiss, Henning
    Stamatis, Georgios
    Kuehl, Hilmar
    Hartung, Verena
    Heusner, Till A.
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (03) : 373 - 378
  • [12] The added value of dual-time-point 18F-FDG PET/CT imaging in the diagnosis of colorectal cancer liver metastases
    Mao, Wujian
    Zhou, Jun
    Qiu, Lin
    Yin, Hongyan
    Tan, Hui
    Shi, Hongcheng
    ABDOMINAL RADIOLOGY, 2020, 45 (04) : 1075 - 1081
  • [13] Brown fat uptake of 18F-FDG on dual time point PET/CT imaging
    Rashmizal, Hairil A. R.
    Noraini, A. R.
    Rossetti, C.
    Jalil, Abdul N.
    SINGAPORE MEDICAL JOURNAL, 2010, 51 (02) : E37 - E39
  • [14] 18F-FDG PET/CT for Response Assessment in Lung Cancer
    Marcus, Charles
    Tajmir, Shahein H.
    Rowe, Steven P.
    Sheikhbahaei, Sara
    Solnes, Lilja B.
    SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (06) : 662 - 672
  • [15] 18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation
    Cornelis, Francois
    Storchios, Vlasios
    Violari, Elena
    Sofocleous, Constantinos T.
    Schoder, Heiko
    Durack, Jeremy C.
    Siegelbaum, Robert H.
    Maybody, Majid
    Humm, John
    Solomon, Stephen B.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (07) : 1052 - 1057
  • [16] 18F-FDG PET/CT in diagnosis of skeletal metastases
    LI Na1 LI Yaming1
    NuclearScienceandTechniques, 2009, 20 (06) : 354 - 358
  • [17] Vanishing Bone Metastases in 18F-FDG PET/CT
    Ainouche, Alida
    Morland, David
    Durot, Carole
    Hoeffel, Christine
    Papathanassiou, Dimitri
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (07) : 559 - 560
  • [18] 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
    Krause, Bernd J.
    Herrmann, Ken
    Wieder, Hinrich
    zum Bueschenfelde, Christian Meyer
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 : 89S - 96S
  • [19] Diagnostic Value of 18F-FDG PET/CT in Comparison to Bone Scintigraphy, CT and 18F-FDG PET for the Detection of Bone Metastasis
    Liu, Ning-Bo
    Zhu, Lei
    Li, Ming-Huan
    Sun, Xiao-Rong
    Hu, Man
    Huo, Zong-Wei
    Xu, Wen-Gui
    Yu, Jin-Ming
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) : 3647 - 3652
  • [20] Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients
    Hahn, Steffen
    Hecktor, Jennifer
    Grabellus, Florian
    Hartung, Verena
    Poepper, Thorsten
    Kimmig, Rainer
    Forsting, Michael
    Antoch, Gerald
    Heusner, Till A.
    ACTA RADIOLOGICA, 2012, 53 (05) : 518 - 523